Ruben A. Mesa, MD, director of the Mays Cancer Center, discusses the potential utility of CAR T-cell therapy in myeloproliferative neoplasms (MPNs) in this video.
Newsroom
Ruben A. Mesa, MD, director of the Mays Cancer Center, discusses the potential utility of CAR T-cell therapy in myeloproliferative neoplasms (MPNs) in this video.